1. Home
  2. FATE vs LSBK Comparison

FATE vs LSBK Comparison

Compare FATE & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • LSBK
  • Stock Information
  • Founded
  • FATE 2007
  • LSBK 1891
  • Country
  • FATE United States
  • LSBK United States
  • Employees
  • FATE N/A
  • LSBK N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • LSBK Savings Institutions
  • Sector
  • FATE Health Care
  • LSBK Finance
  • Exchange
  • FATE Nasdaq
  • LSBK Nasdaq
  • Market Cap
  • FATE 108.2M
  • LSBK 90.3M
  • IPO Year
  • FATE 2013
  • LSBK 2006
  • Fundamental
  • Price
  • FATE $0.77
  • LSBK $15.97
  • Analyst Decision
  • FATE Hold
  • LSBK
  • Analyst Count
  • FATE 9
  • LSBK 0
  • Target Price
  • FATE $5.50
  • LSBK N/A
  • AVG Volume (30 Days)
  • FATE 1.6M
  • LSBK 4.9K
  • Earning Date
  • FATE 03-05-2025
  • LSBK 04-21-2025
  • Dividend Yield
  • FATE N/A
  • LSBK 4.51%
  • EPS Growth
  • FATE N/A
  • LSBK 6.97
  • EPS
  • FATE N/A
  • LSBK 0.88
  • Revenue
  • FATE $13,631,000.00
  • LSBK $25,846,000.00
  • Revenue This Year
  • FATE N/A
  • LSBK N/A
  • Revenue Next Year
  • FATE N/A
  • LSBK N/A
  • P/E Ratio
  • FATE N/A
  • LSBK $18.06
  • Revenue Growth
  • FATE N/A
  • LSBK N/A
  • 52 Week Low
  • FATE $0.74
  • LSBK $10.30
  • 52 Week High
  • FATE $7.35
  • LSBK $16.95
  • Technical
  • Relative Strength Index (RSI)
  • FATE 33.08
  • LSBK 49.59
  • Support Level
  • FATE $0.83
  • LSBK $15.71
  • Resistance Level
  • FATE $0.96
  • LSBK $16.12
  • Average True Range (ATR)
  • FATE 0.06
  • LSBK 0.26
  • MACD
  • FATE -0.00
  • LSBK -0.05
  • Stochastic Oscillator
  • FATE 11.54
  • LSBK 6.17

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

Share on Social Networks: